Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Oncotarget|February 9, 2018
Mitochondrial dysfunction activates lysosomal-dependent mitophagy selectively in cancer cellsThomas G Biel, V Ashutosh RaoPlos One|December 29, 2016
Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA IntegrityKaytee L Pokrzywinski, Thomas G Biel, Dmitry Kryndushkin, et al.Cell Death & Disease|June 17, 2020
Mitochondrial dysfunction generates aggregates that resist lysosomal degradation in human breast cancer cellsThomas G Biel, Baikuntha Aryal, Michael H Gerber, et al.Journal of Pharmaceutical Sciences|January 8, 2025
Analytical characterization of aberrant trisulfide bond formation in therapeutic proteins and their impact on product qualityJordan D Pritts, Vincent M Falkowski, Thomas G Biel, et al.Antioxidants & Redox Signaling|August 21, 2012
Iron chelators with topoisomerase-inhibitory activity and their anticancer applicationsV Ashutosh RaoCancer Research|December 15, 2019
Targeting Mitochondrial Fission to Trigger Cancer Cell DeathV Ashutosh RaoBiology of Sex Differences|June 17, 2018
Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive ratsKaytee L Pokrzywinski, Thomas G Biel, Elliot T Rosen, et al.Plos One|December 6, 2022
SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteinsAlicia M Matthews, Thomas G Biel, Uriel Ortega-Rodriguez, et al.Pharmaceutical Research|October 27, 2015
Comparative Effects of Metal-Catalyzed Oxidizing Systems on Carbonylation and Integrity of Therapeutic ProteinsDmitry Kryndushkin, V Ashutosh RaoPharmaceutical Research|September 4, 2014
Metal-mediated protein oxidation: applications of a modified ELISA-based carbonyl detection assay for complex proteinsHiroshi Uehara, V Ashutosh RaoPageof 7